Cargando…
Feasibility of Targeting Traf2-and-Nck-Interacting Kinase in Synovial Sarcoma
Background: The treatment of patients with metastatic synovial sarcoma is still challenging, and the development of new molecular therapeutics is desirable. Dysregulation of Wnt signaling has been implicated in synovial sarcoma. Traf2-and-Nck-interacting kinase (TNIK) is an essential transcriptional...
Autores principales: | Sekita, Tetsuya, Yamada, Tesshi, Kobayashi, Eisuke, Yoshida, Akihiko, Hirozane, Toru, Kawai, Akira, Uno, Yuko, Moriyama, Hideki, Sawa, Masaaki, Nagakawa, Yuichi, Tsuchida, Akihiko, Matsumoto, Morio, Nakamura, Masaya, Nakayama, Robert, Masuda, Mari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281028/ https://www.ncbi.nlm.nih.gov/pubmed/32429395 http://dx.doi.org/10.3390/cancers12051258 |
Ejemplares similares
-
Pharmacological blockage of transforming growth factor-β signalling by a Traf2- and Nck-interacting kinase inhibitor, NCB-0846
por: Sugano, Teppei, et al.
Publicado: (2020) -
Direct conversion of osteosarcoma to adipocytes by targeting TNIK
por: Hirozane, Toru, et al.
Publicado: (2021) -
Prognostic significance of Traf2- and Nck- interacting kinase (TNIK) in colorectal cancer
por: Takahashi, Hidenori, et al.
Publicado: (2015) -
Prognostic value of preoperative high-sensitivity modified Glasgow prognostic score in advanced colon cancer: a retrospective observational study
por: Kasahara, Kenta, et al.
Publicado: (2022) -
Pseudomyogenic hemangioendothelioma of bone treated with denosumab: a case report
por: Otani, Shinya, et al.
Publicado: (2019)